Schonfeld Strategic Advisors LLC
Position in SRPT — Sarepta Therapeutics, Inc.
CIK 1665241
NEW YORK, NY
Position in SRPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,479,931
+$1,950,109 QoQ
Shares Held
138,004
+460.5% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#75
of 323 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Derivatives in SRPT
reported options exposure · as of Sep 30, 2023CallValue
$8,182,350
CallShares
67,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. SRPT ranks #49 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in SRPT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,479,931 | 138,004 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $529,822 | 24,620 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $457,161 | 23,724 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,553,466 | 90,846 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,172,045 | 49,703 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,007,761 | 49,410 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,663,500 | 61,362 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,324,970 | 14,715 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $3,048,923 | 31,618 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,182,350 | 67,500 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $10,997,684 | 90,725 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,303,593 | 89,972 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,676,426 | 12,163 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $18,891,597 | 145,791 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,805,892 | 70,616 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,442,245 | 72,602 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,629,909 | 33,665 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,665,035 | 40,700 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $255,220 | 3,283 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $730,468 | 9,801 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $649,396 | 3,809 | Shares | Sole | 2021-02-16 | |
| 2020-12-31 | $11,934,300 | 70,000 | Call | Sole | 2021-02-16 | |
| 2020-09-30 | $912,795 | 6,500 | Shares | Sole | 2020-11-19 | |
| No filing history on record for this holder in this stock. | ||||||